Triglyceride accumulation: Inhibitory effects of Tangzhiqing formula

Alternative Therapies in Health and Medicine

Volumn 19, Issue 5, 2013, Pages 20-29

  An, Yating ^a   Liu, Xuefeng ^a   Qian, Qian ^a   Zhang, Deqin ^a   Li, Yuhong ^a   Gao, Xiumei ^a   Zhang, Yi ^a   Wang, Tao ^a  

^a TIANJIN UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; HERBACEOUS AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; TANGZHIQING; TRIACYLGLYCEROL;

ADIPOCYTE; ANIMAL; ARTICLE; BLOOD; C57BL MOUSE; CELL STRAIN 3T3; DRUG EFFECT; GENETICS; GLUCOSE BLOOD LEVEL; LIPID METABOLISM; LIVER; METABOLISM; MOUSE; MUSCLE; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE;

3T3-L1 CELLS; ADIPOCYTES; AMP-ACTIVATED PROTEIN KINASES; ANIMALS; BLOOD GLUCOSE; DRUGS, CHINESE HERBAL; FATTY ACIDS; LIPID METABOLISM; LIVER; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MUSCLES; SIGNAL TRANSDUCTION; TRIGLYCERIDES;

EID: 84884178239     PISSN: 10786791     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Misra P. AMP activated protein kinase: a next generation target for total metabolic control. Expert Opin Ther Targets. 2008;12(1):91-100.
2. Hardie DG. Role of AMP-activated protein kinase in the metabolic syndrome and in heart disease. FEBS Lett. 2008;582(1):81-89.
3. Steinberg GR, Kemp BE. AMPK in health and disease. Physiol Rev. 2009;89(3):1025-1078.
4. Towler MC, Hardie DG. AMP-activated protein kinase in metabolic control and insulin signaling. Circ Res. 2007;100(3):328-341.
5. Zhang BB, Zhou G, Li C. AMPK: an emerging drug target for diabetes and the metabolic syndrome. Cell Metab. 2009;9(5):407-416.
6. Hardie DG, Sakamoto K. AMPK: a key sensor of fuel and energy status in skeletal muscle. Physiology (Bethesda). Feb 2006;21:48-60.
7. Tao W, Deqin Z, Yuhong L, et al. Regulation effects on abnormal glucose and lipid metabolism of TZQ-F, a new kind of Traditional Chinese Medicine. J Ethnopharmacol. 2010;128(3):575-582.
8. Zhang Y, Qian Q, Ge D, et al. Identification of benzophenone C-glucosides from mango tree leaves and their inhibitory effect on triglyceride accumulation in 3T3-L1 adipocytes. J Agric Food Chem. 2011;59(21):11526-11533.
9. Peterson JM, Aja S, Wei Z, Wong GW. CTRP1 protein enhances fatty acid oxidation via AMP-activated protein kinase (AMPK) activation and acetyl-CoA carboxylase (ACC) inhibition. J Biol Chem. 2012;287(2):1576-1587.
10. Srinivasan K, Ramarao P. Animal models in type 2 diabetes research: an overview. Indian J Med Res. 2007;125(3):451-472.
11. Chen ZP, McConell GK, Michell BJ, Snow RJ, Canny BJ, Kemp BE. AMPK signaling in contracting human skeletal muscle: acetyl-CoA carboxylase and NO synthase phosphorylation. Am J Physiol Endocrinol Metab. 2000;279(5):E1202-E1206.
12. Park SH, Gammon SR, Knippers JD, Paulsen SR, Rubink DS, Winder WW. Phosphorylation-activity relationships of AMPK and acetyl-CoA carboxylase in muscle. J Appl Physiol. 2002;92(6):2475-2482.
13. Hotamisligil GS, Budavari A, Murray D, Spiegelman BM. Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes: central role of tumor necrosis factor-alpha. J Clin Invest. 1994;94(4):1543-1549.
14. Youd JM, Rattigan S, Clark MG. Acute impairment of insulin-mediated capillary recruitment and glucose uptake in rat skeletal muscle in vivo by TNF-alpha. Diabetes. 2000;49(11):1904-1909.
15. An Z, Wang H, Song P, Zhang M, Geng X, Zou MH. Nicotine-induced activation of AMP-activated protein kinase inhibits fatty acid synthase in 3T3L1 adipocytes: a role for oxidant stress. J Biol Chem. 2007;282(37):26793-26801.
16. Bruce CR, Dyck DJ. Cytokine regulation of skeletal muscle fatty acid metabolism: effect of interleukin-6 and tumor necrosis factor-alpha. Am J Physiol Endocrinol Metab. 2004;287(4):E616-E621.
17. Dyck DJ, Heigenhauser GJ, Bruce CR. The role of adipokines as regulators of skeletal muscle fatty acid metabolism and insulin sensitivity. Acta Physiol (Oxf). 2006;186(1):5-16.
18. Hardie DG, Pan DA. Regulation of fatty acid synthesis and oxidation by the AMP-activated protein kinase. Biochem Soc Trans. Nov 2002;30(pt 6):1064-1070.
19. Jones RG, Plas DR, Kubek S, et al. AMP-activated protein kinase induces a p53-dependent metabolic checkpoint. Mol Cell. 2005;18(3):283-293.
20. Merrill GF, Kurth EJ, Hardie DG, Winder WW. AICA riboside increases AMPactivated protein kinase, fatty acid oxidation, and glucose uptake in rat muscle. Am J Physiol. 1997;273(6 pt 1):E1107-E1112.
21. Watt MJ, Holmes AG, Pinnamaneni SK, et al. Regulation of HSL serine phosphorylation in skeletal muscle and adipose tissue. Am J Physiol Endocrinol Metab. 2006;290(3):E500-E508.
22. Pellinen J, Szentirmai E. The effects of C75, an inhibitor of fatty acid synthase, on sleep and metabolism in mice. PLoS One. 2012;7(2):e30651.
23. Yamauchi T, Kamon J, Minokoshi Y, et al. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med. 2002;8(11):1288-1295.
24. Horton JD, Goldstein JL, Brown MS. SREBPs: transcriptional mediators of lipid homeostasis. Cold Spring Harb Symp Quant Biol. 2002;67:491-498.